Viking Therapeutics (VKTX) has had the highest return between 2022 and 2024 by a mid-cap US stock, returning 1,193.1%.
Viking Therapeutics (VKTX) has had the highest return between 2022 and 2024 by a mid-cap US stock, returning 1,193.1%.
Mid-cap stocks are treated as having a market cap between $2B and $10B.